In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
As of close of business last night, Ensysce Biosciences Inc’s stock clocked out at $7.92, down -3.41% from its previous closing price of $8.20. In other words, the price has decreased by -$3.41 from its previous closing price. On the day, 69515.0 shares were traded. ENSC stock price reached its highest trading level at $8.23 during the session, while it also had its lowest trading level at $7.5.
Ratios:
To gain a deeper understanding of ENSC’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.24 and its Current Ratio is at 3.24. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.00.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ENSC now has a Market Capitalization of 10335046 and an Enterprise Value of 5088810. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.34 while its Price-to-Book (P/B) ratio in mrq is 1.06. Its current Enterprise Value per Revenue stands at 3.539.
Stock Price History:
The Beta on a monthly basis for ENSC is 0.56, which has changed by -0.6255319 over the last 52 weeks, in comparison to a change of 0.23806548 over the same period for the S&P500. Over the past 52 weeks, ENSC has reached a high of $30.90, while it has fallen to a 52-week low of $2.12. The 50-Day Moving Average of the stock is -4.55%, while the 200-Day Moving Average is calculated to be 6.05%.
Shares Statistics:
It appears that ENSC traded 1.86M shares on average per day over the past three months and 82180 shares per day over the past ten days. A total of 1.30M shares are outstanding, with a floating share count of 1.28M. Insiders hold about 1.53% of the company’s shares, while institutions hold 26.55% stake in the company. Shares short for ENSC as of 1730332800 were 6354589 with a Short Ratio of 0.02, compared to 1727654400 on 180215. Therefore, it implies a Short% of Shares Outstanding of 6354589 and a Short% of Float of 45.080003000000005.
Earnings Estimates
Currently, 1 analysts are dedicated to thoroughly evaluating and rating the performance of Ensysce Biosciences Inc (ENSC) in the stock market.The consensus estimate for the next quarter is -$2.25, with high estimates of -$2.25 and low estimates of -$2.25.
Analysts are recommending an EPS of between -$12.45 and -$12.45 for the fiscal current year, implying an average EPS of -$12.45. EPS for the following year is -$10.2, with 1.0 analysts recommending between -$10.2 and -$10.2.
Revenue Estimates
In the current quarter, 2 analysts expect revenue to total $245k. It ranges from a high estimate of $400k to a low estimate of $90k. As of the current estimate, Ensysce Biosciences Inc’s year-ago sales were $515.03k
A total of 2 analysts have provided revenue estimates for ENSC’s current fiscal year. The highest revenue estimate was $4.3M, while the lowest revenue estimate was $4M, resulting in an average revenue estimate of $4.15M. In the same quarter a year ago, actual revenue was $2.23M
